Aims: To evaluate the influence of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism on lipid levels in patients with Type 2 diabetes.
Patients And Methods: 109 patients with Type 2 diabetes were included. The patients were not on any lipid-lowering treatment.